Human Respiratory Syncytial Virus: Infection and Pathology

Seminars in Respiratory and Critical Care Medicine

Volumn 37, Issue 4, 2016, Pages 522-537

  Bohmwald, Karen ^a   Espinoza, Janyra A ^a   Rey Jurado, Emma ^a   Gómez, Roberto S ^a   González, Pablo A ^a   Bueno, Susan M ^a   Riedel, Claudia A ^b   Kalergis, Alexis M ^a,b,c,d  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSIDAD ANDRÉS BELLO   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d INSERM   (France)

Author keywords

adaptive immune response; central nervous system; extrapulmonary manifestations; human respiratory syncytial virus; innate immune response; virulence factors

Indexed keywords

ADAPTIVE IMMUNITY; ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNE RESPONSE; INNATE IMMUNITY; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS PATHOGENESIS; COMPLICATION; IMMUNE EVASION; IMMUNOLOGY; INFANT; LUNG; NEWBORN; PATHOLOGY; RESPIRATORY TRACT INFECTION; VIROLOGY;

HUMANS; IMMUNE EVASION; INFANT; INFANT, NEWBORN; LUNG; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RESPIRATORY TRACT INFECTIONS;

EID: 84982676254     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0036-1584799     Document Type: Article

References (181)

1. Calvo C., García-García M. L., Blanco C., et al. Multiple simultaneous viral infections in infants with acute respiratory tract infections in Spain. J Clin Virol: 2008; 42 3 268 272
2. Ogra P. L. Respiratory syncytial virus: the virus, the disease and the immune response. Paediatr Respir Rev: 2004; 5 (Suppl A): S119 S126
3. González P. A., Prado C. E., Leiva E. D., et al. Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci U S A: 2008; 105 39 14999 15004
4. Bueno S. M., González P. A., Pacheco R., et al. Host immunity during RSV pathogenesis. Int Immunopharmacol: 2008; 8 10 1320 1329
5. Collins P. L., Melero J. A. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res: 2011; 162 1-2 80 99
6. Sweetman L. L., Ng Y. T., Butler I. J., Bodensteiner J. B. Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol: 2005; 32 5 307 310
7. Boyce T. G., Mellen B. G., Mitchel E. F. Jr, Wright P. F., Griffin M. R. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr: 2000; 137 6 865 870
8. Wang E. E., Law B. J., Boucher F. D., et al. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. J Pediatr: 1996; 129 3 390 395
9. Aujard Y., Fauroux B. Risk factors for severe respiratory syncytial virus infection in infants. Respir Med: 2002; 96 (Suppl B): S9 S14
10. Navas L., Wang E., de Carvalho V., Robinson J.; Pediatric Investigators Collaborative Network on Infections in Canada. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. J Pediatr: 1992; 121 3 348 354
11. Collins P. L., Graham B. S. Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol: 2008; 82 5 2040 2055
12. Nair H., Nokes D. J., Gessner B. D., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet: 2010; 375 9725 1545 1555
13. Paramore L. C., Ciuryla V., Ciesla G., Liu L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics: 2004; 22 5 275 284
14. Halfhide C. P., Flanagan B. F., Brearey S. P., et al. Respiratory syncytial virus binds and undergoes transcription in neutrophils from the blood and airways of infants with severe bronchiolitis. J Infect Dis: 2011; 204 3 451 458
15. Hall C. B., Douglas R. G. Jr, Schnabel K. C., Geiman J. M. Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun: 1981; 33 3 779 783
16. Storey S. Respiratory syncytial virus market. Nat Rev Drug Discov: 2010; 9 1 15 16
17. Dudas R. A., Karron R. A. Respiratory syncytial virus vaccines. Clin Microbiol Rev: 1998; 11 3 430 439
18. van Drunen Littel-van den Hurk S., Watkiss E. R. Pathogenesis of respiratory syncytial virus. Curr Opin Virol: 2012; 2 3 300 305
19. González P. A., Bueno S. M., Riedel C. A., Kalergis A. M. Impairment of T cell immunity by the respiratory syncytial virus: targeting virulence mechanisms for therapy and prophylaxis. Curr Med Chem: 2009; 16 34 4609 4625
20. Bont L., Versteegh J., Swelsen W. T., et al. Natural reinfection with respiratory syncytial virus does not boost virus-specific T-cell immunity. Pediatr Res: 2002; 52 3 363 367
21. Guo-Parke H., Canning P., Douglas I., et al. Relative respiratory syncytial virus cytopathogenesis in upper and lower respiratory tract epithelium. Am J Respir Crit Care Med: 2013; 188 7 842 851
22. Pickles R. J., DeVincenzo J. P. Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis. J Pathol: 2015; 235 2 266 276
23. Rudraraju R., Jones B. G., Sealy R., Surman S. L., Hurwitz J. L. Respiratory syncytial virus: current progress in vaccine development. Viruses: 2013; 5 2 577 594
24. Lanari M., Vandini S., Arcuri S., Galletti S., Faldella G. The use of humanized monoclonal antibodies for the prevention of respiratory syncytial virus infection. Clin Dev Immunol: 2013; 2013 359683
25. Lanari M., Silvestri M., Rossi G. A. Clinical and pharmacological aspects of immunoprophylaxis for respiratory syncytial virus infection in high-risk infants. Curr Drug Metab: 2013; 14 2 216 225
26. Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection- A systematic review. Crit Care: 2006; 10 4 R107
27. Esposito S., Salice P., Bosis S., et al. Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection. BMC Infect Dis: 2010; 10 305
28. Kirin B. K., Topić R. Z., Dodig S. Hepatitis during respiratory syncytial virus infection- A case report. Biochem Med (Zagreb): 2013; 23 1 112 116
29. Hacking D., Hull J. Respiratory syncytial virus-viral biology and the host response. J Infect: 2002; 45 1 18 24
30. Chanock R., Roizman B., Myers R. Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA). I. Isolation, properties and characterization. Am J Hyg: 1957; 66 3 281 290
31. Collins P., Chanock R., Murphy B. Respiratory Syncytial Virus. Philadelphia, PA Lippincott Williams & Wilkins: 2001
32. Lay M. K., González P. A., León M. A., et al. Advances in understanding respiratory syncytial virus infection in airway epithelial cells and consequential effects on the immune response. Microbes Infect: 2013; 15 3 230 242
33. McLellan J. S., Chen M., Joyce M. G., et al. Structure-based design of a fusion glycoprotein vaccine for respiratory syncytial virus. Science: 2013; 342 6158 592 598
34. Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy- A review. Virus Genes: 2006; 33 2 235 252
35. Ternette N., Tippler B., Uberla K., Grunwald T. Immunogenicity and efficacy of codon optimized DNA vaccines encoding the F-protein of respiratory syncytial virus. Vaccine: 2007; 25 41 7271 7279
36. Mastrangelo P., Hegele R. G. RSV fusion: time for a new model. Viruses: 2013; 5 3 873 885
37. Marr N., Turvey S. E. Role of human TLR4 in respiratory syncytial virus-induced NF-κB activation, viral entry and replication. Innate Immun: 2012; 18 6 856 865
38. Behera A. K., Matsuse H., Kumar M., Kong X., Lockey R. F., Mohapatra S. S. Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection. Biochem Biophys Res Commun: 2001; 280 1 188 195
39. Tayyari F., Marchant D., Moraes T. J., Duan W., Mastrangelo P., Hegele R. G. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med: 2011; 17 9 1132 1135
40. Openshaw P. J., Tregoning J. S. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev: 2005; 18 3 541 555
41. Krusat T., Streckert H. J. Heparin-dependent attachment of respiratory syncytial virus (RSV) to host cells. Arch Virol: 1997; 142 6 1247 1254
42. Malhotra R., Ward M., Bright H., et al. Isolation and characterisation of potential respiratory syncytial virus receptor(s) on epithelial cells. Microbes Infect: 2003; 5 2 123 133
43. Bukreyev A., Yang L., Fricke J., et al. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J Virol: 2008; 82 24 12191 12204
44. Harcourt J., Alvarez R., Jones L. P., Henderson C., Anderson L. J., Tripp R. A. Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses. J Immunol: 2006; 176 3 1600 1608
45. Tripp R. A., Jones L. P., Haynes L. M., Zheng H., Murphy P. M., Anderson L. J. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol: 2001; 2 8 732 738
46. Langedijk J. P., de Groot B. L., Berendsen H. J., van Oirschot J. T. Structural homology of the central conserved region of the attachment protein G of respiratory syncytial virus with the fourth subdomain of 55-kDa tumor necrosis factor receptor. Virology: 1998; 243 2 293 302
47. Rixon H. W., Brown G., Aitken J., McDonald T., Graham S., Sugrue R. J. The small hydrophobic (SH) protein accumulates within lipid-raft structures of the Golgi complex during respiratory syncytial virus infection. J Gen Virol: 2004; 85 Pt 5 1153 1165
48. Fuentes S., Tran K. C., Luthra P., Teng M. N., He B. Function of the respiratory syncytial virus small hydrophobic protein. J Virol: 2007; 81 15 8361 8366
49. Gan S. W., Ng L., Lin X., Gong X., Torres J. Structure and ion channel activity of the human respiratory syncytial virus (hRSV) small hydrophobic protein transmembrane domain. Protein Sci: 2008; 17 5 813 820
50. Triantafilou K., Kar S., Vakakis E., Kotecha S., Triantafilou M. Human respiratory syncytial virus viroporin SH: a viral recognition pathway used by the host to signal inflammasome activation. Thorax: 2013; 68 1 66 75
51. Gan S. W., Tan E., Lin X., et al. The small hydrophobic protein of the human respiratory syncytial virus forms pentameric ion channels. J Biol Chem: 2012; 287 29 24671 24689
52. Ruigrok R. W., Crépin T. Nucleoproteins of negative strand RNA viruses; RNA binding, oligomerisation and binding to polymerase co-factor. Viruses: 2010; 2 1 27 32
53. Tawar R. G., Duquerroy S., Vonrhein C., et al. Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus. Science: 2009; 326 5957 1279 1283
54. Le Mercier P., Garcin D., Hausmann S., Kolakofsky D. Ambisense sendai viruses are inherently unstable but are useful to study viral RNA synthesis. J Virol: 2002; 76 11 5492 5502
55. El Omari K., Dhaliwal B., Ren J., et al. Structures of respiratory syncytial virus nucleocapsid protein from two crystal forms: details of potential packing interactions in the native helical form. Acta Crystallogr Sect F Struct Biol Cryst Commun: 2011; 67 Pt 10 1179 1183
56. Hanna S., Tibby S. M., Durward A., Murdoch I. A. Incidence of hyponatraemia and hyponatraemic seizures in severe respiratory syncytial virus bronchiolitis. Acta Paediatr: 2003; 92 4 430 434
57. Lifland A. W., Jung J., Alonas E., Zurla C., Crowe J. E. Jr, Santangelo P. J. Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol: 2012; 86 15 8245 8258
58. Céspedes P. F., Bueno S. M., Ramírez B. A., et al. Surface expression of the hRSV nucleoprotein impairs immunological synapse formation with T cells. Proc Natl Acad Sci USA: 2014; 111 31 E3214 E3223
59. Cowton V. M., McGivern D. R., Fearns R. Unravelling the complexities of respiratory syncytial virus RNA synthesis. J Gen Virol: 2006; 87 Pt 7 1805 1821
60. Slack M. S., Easton A. J. Characterization of the interaction of the human respiratory syncytial virus phosphoprotein and nucleocapsid protein using the two-hybrid system. Virus Res: 1998; 55 2 167 176
61. Tran T. L., Castagné N., Bhella D., et al. The nine C-terminal amino acids of the respiratory syncytial virus protein P are necessary and sufficient for binding to ribonucleoprotein complexes in which six ribonucleotides are contacted per N protein protomer. J Gen Virol: 2007; 88 (Pt 1): 196 206
62. Sourimant J., Rameix-Welti M. A., Gaillard A. L., et al. Fine mapping and characterization of the L-polymerase-binding domain of the respiratory syncytial virus phosphoprotein. J Virol: 2015; 89 8 4421 4433
63. Lu B., Ma C. H., Brazas R., Jin H. The major phosphorylation sites of the respiratory syncytial virus phosphoprotein are dispensable for virus replication in vitro. J Virol: 2002; 76 21 10776 10784
64. Grosfeld H., Hill M. G., Collins P. L. RNA replication by respiratory syncytial virus (RSV) is directed by the N, P, and L proteins; transcription also occurs under these conditions but requires RSV superinfection for efficient synthesis of full-length mRNA. J Virol: 1995; 69 9 5677 5686
65. Fearns R., Collins P. L., Peeples M. E. Functional analysis of the genomic and antigenomic promoters of human respiratory syncytial virus. J Virol: 2000; 74 13 6006 6014
66. Hardy R. W., Wertz G. W. The product of the respiratory syncytial virus M2 gene ORF1 enhances readthrough of intergenic junctions during viral transcription. J Virol: 1998; 72 1 520 526
67. Kuo L., Fearns R., Collins P. L. The structurally diverse intergenic regions of respiratory syncytial virus do not modulate sequential transcription by a dicistronic minigenome. J Virol: 1996; 70 9 6143 6150
68. Teng M. N., Collins P. L. Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J Virol: 1998; 72 7 5707 5716
69. Ghildyal R., Baulch-Brown C., Mills J., Meanger J. The matrix protein of Human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch Virol: 2003; 148 7 1419 1429
70. Ghildyal R., Ho A., Wagstaff K. M., et al. Nuclear import of the respiratory syncytial virus matrix protein is mediated by importin beta1 independent of importin alpha. Biochemistry: 2005; 44 38 12887 12895
71. Ghildyal R., Ho A., Dias M., et al. The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism. J Virol: 2009; 83 11 5353 5362
72. Bian T., Gibbs J. D., Örvell C., Imani F. Respiratory syncytial virus matrix protein induces lung epithelial cell cycle arrest through a p53 dependent pathway. PLoS ONE: 2012; 7 5 e38052
73. Mitra R., Baviskar P., Duncan-Decocq R. R., Patel D., Oomens A. G. The human respiratory syncytial virus matrix protein is required for maturation of viral filaments. J Virol: 2012; 86 8 4432 4443
74. Li D., Jans D. A., Bardin P. G., Meanger J., Mills J., Ghildyal R. Association of respiratory syncytial virus M protein with viral nucleocapsids is mediated by the M2-1 protein. J Virol: 2008; 82 17 8863 8870
75. Ghildyal R., Mills J., Murray M., Vardaxis N., Meanger J. Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J Gen Virol: 2002; 83 Pt 4 753 757
76. Ghildyal R., Li D., Peroulis I., et al. Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. J Gen Virol: 2005; 86 Pt 7 1879 1884
77. Fearns R., Collins P. L. Role of the M2-1 transcription antitermination protein of respiratory syncytial virus in sequential transcription. J Virol: 1999; 73 7 5852 5864
78. Tran T. L., Castagné N., Dubosclard V., et al. The respiratory syncytial virus M2-1 protein forms tetramers and interacts with RNA and P in a competitive manner. J Virol: 2009; 83 13 6363 6374
79. Kiss G., Holl J. M., Williams G. M., et al. Structural analysis of respiratory syncytial virus reveals the position of M2-1 between the matrix protein and the ribonucleoprotein complex. J Virol: 2014; 88 13 7602 7617
80. Cartee T. L., Wertz G. W. Respiratory syncytial virus M2-1 protein requires phosphorylation for efficient function and binds viral RNA during infection. J Virol: 2001; 75 24 12188 12197
81. Mason S. W., Aberg E., Lawetz C., DeLong R., Whitehead P., Liuzzi M. Interaction between human respiratory syncytial virus (RSV) M2-1 and P proteins is required for reconstitution of M2-1-dependent RSV minigenome activity. J Virol: 2003; 77 19 10670 10676
82. Reimers K., Buchholz K., Werchau H. Respiratory syncytial virus M2-1 protein induces the activation of nuclear factor kappa B. Virology: 2005; 331 2 260 268
83. Cheng X., Park H., Zhou H., Jin H. Overexpression of the M2-2 protein of respiratory syncytial virus inhibits viral replication. J Virol: 2005; 79 22 13943 13952
84. Bermingham A., Collins P. L. The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription. Proc Natl Acad Sci U S A: 1999; 96 20 11259 11264
85. Munir S., Hillyer P., Le Nouën C., et al. Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. PLoS Pathog: 2011; 7 4 e1001336
86. Munir S., Le Nouen C., Luongo C., Buchholz U. J., Collins P. L., Bukreyev A. Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. J Virol: 2008; 82 17 8780 8796
87. Spann K. M., Tran K. C., Collins P. L. Effects of nonstructural proteins NS1 and NS2 of human respiratory syncytial virus on interferon regulatory factor 3, NF-kappaB, and proinflammatory cytokines. J Virol: 2005; 79 9 5353 5362
88. Wright P. F., Karron R. A., Madhi S. A., et al. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. J Infect Dis: 2006; 193 4 573 581
89. Elliott J., Lynch O. T., Suessmuth Y., et al. Respiratory syncytial virus NS1 protein degrades STAT2 by using the Elongin-Cullin E3 ligase. J Virol: 2007; 81 7 3428 3436
90. Wu W., Tran K. C., Teng M. N., et al. The interactome of the human respiratory syncytial virus NS1 protein highlights multiple effects on host cell biology. J Virol: 2012; 86 15 7777 7789
91. Qin L., Peng D., Hu C., et al. Differentiation of Th subsets inhibited by nonstructural proteins of respiratory syncytial virus is mediated by ubiquitination. PLoS ONE: 2014; 9 7 e101469
92. Lambert D. M. Role of oligosaccharides in the structure and function of respiratory syncytial virus glycoproteins. Virology: 1988; 164 2 458 466
93. San-Juan-Vergara H., Sampayo-Escobar V., Reyes N., et al. Cholesterol-rich microdomains as docking platforms for respiratory syncytial virus in normal human bronchial epithelial cells. J Virol: 2012; 86 3 1832 1843
94. Asenjo A., Rodríguez L., Villanueva N. Determination of phosphorylated residues from human respiratory syncytial virus P protein that are dynamically dephosphorylated by cellular phosphatases: a possible role for serine 54. J Gen Virol: 2005; 86 Pt 4 1109 1120
95. Carromeu C., Simabuco F. M., Tamura R. E., Farinha Arcieri L. E., Ventura A. M. Intracellular localization of human respiratory syncytial virus L protein. Arch Virol: 2007; 152 12 2259 2263
96. Burke E., Mahoney N. M., Almo S. C., Barik S. Profilin is required for optimal actin-dependent transcription of respiratory syncytial virus genome RNA. J Virol: 2000; 74 2 669 675
97. Brown G., Rixon H. W., Steel J., et al. Evidence for an association between heat shock protein 70 and the respiratory syncytial virus polymerase complex within lipid-raft membranes during virus infection. Virology: 2005; 338 1 69 80
98. Munday D. C., Wu W., Smith N., et al. Interactome analysis of the human respiratory syncytial virus RNA polymerase complex identifies protein chaperones as important cofactors that promote L-protein stability and RNA synthesis. J Virol: 2015; 89 2 917 930
99. Mink M. A., Stec D. S., Collins P. L. Nucleotide sequences of the 3′ leader and 5′ trailer regions of human respiratory syncytial virus genomic RNA. Virology: 1991; 185 2 615 624
100. Rodriguez R., Ramilo O. Respiratory syncytial virus: how, why and what to do. J Infect: 2014; 68 01 S115 S118
101. Low K. W., Tan T., Ng K., Tan B. H., Sugrue R. J. The RSV F and G glycoproteins interact to form a complex on the surface of infected cells. Biochem Biophys Res Commun: 2008; 366 2 308 313
102. Jumat M. R., Yan Y., Ravi L. I., et al. Morphogenesis of respiratory syncytial virus in human primary nasal ciliated epithelial cells occurs at surface membrane microdomains that are distinct from cilia. Virology: 2015; 484 395 411
103. Shaikh F. Y., Cox R. G., Lifland A. W., et al. A critical phenylalanine residue in the respiratory syncytial virus fusion protein cytoplasmic tail mediates assembly of internal viral proteins into viral filaments and particles. MBio: 2012; 3 1 270 271
104. Ravi L. I., Liang L., Wong P. S., Brown G., Tan B. H., Sugrue R. J. Increased hydroxymethylglutaryl coenzyme A reductase activity during respiratory syncytial virus infection mediates actin dependent inter-cellular virus transmission. Antiviral Res: 2013; 100 1 259 268
105. Utley T. J., Ducharme N. A., Varthakavi V., et al. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc Natl Acad Sci U S A: 2008; 105 29 10209 10214
106. Aherne W., Bird T., Court S. D., Gardner P. S., McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol: 1970; 23 1 7 18
107. Zeng R., Cui Y., Hai Y., Liu Y. Pattern recognition receptors for respiratory syncytial virus infection and design of vaccines. Virus Res: 2012; 167 2 138 145
108. Groskreutz D. J., Monick M. M., Powers L. S., Yarovinsky T. O., Look D. C., Hunninghake G. W. Respiratory syncytial virus induces TLR3 protein and protein kinase R, leading to increased double-stranded RNA responsiveness in airway epithelial cells. J Immunol: 2006; 176 3 1733 1740
109. Lukacs N. W., Smit J. J., Mukherjee S., Morris S. B., Nunez G., Lindell D. M. Respiratory virus-induced TLR7 activation controls IL-17-associated increased mucus via IL-23 regulation. J Immunol: 2010; 185 4 2231 2239
110. Murawski M. R., Bowen G. N., Cerny A. M., et al. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J Virol: 2009; 83 3 1492 1500
111. Baum A., García-Sastre A. Induction of type I interferon by RNA viruses: cellular receptors and their substrates. Amino Acids: 2010; 38 5 1283 1299
112. Rudd B. D., Burstein E., Duckett C. S., Li X., Lukacs N. W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol: 2005; 79 6 3350 3357
113. Arnold R., König W. Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J Immunol: 2005; 174 11 7359 7367
114. Jaovisidha P., Peeples M. E., Brees A. A., Carpenter L. R., Moy J. N. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J Immunol: 1999; 163 5 2816 2820
115. Bals R., Hiemstra P. S. Innate immunity in the lung: how epithelial cells fight against respiratory pathogens. Eur Respir J: 2004; 23 2 327 333
116. LeVine A. M., Whitsett J. A., Hartshorn K. L., Crouch E. C., Korfhagen T. R. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol: 2001; 167 10 5868 5873
117. Crouch E., Wright J. R. Surfactant proteins a and d and pulmonary host defense. Annu Rev Physiol: 2001; 63 521 554
118. Wright J. R. Immunomodulatory functions of surfactant. Physiol Rev: 1997; 77 4 931 962
119. Hickling T. P., Bright H., Wing K., et al. A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur J Immunol: 1999; 29 11 3478 3484
120. Lee H. C., Headley M. B., Loo Y. M., et al. Thymic stromal lymphopoietin is induced by respiratory syncytial virus-infected airway epithelial cells and promotes a type 2 response to infection. J Allergy Clin Immunol: 2012; 130 5 1187 1196.e5
121. Qiao J., Li A., Jin X. TSLP from RSV-stimulated rat airway epithelial cells activates myeloid dendritic cells. Immunol Cell Biol: 2011; 89 2 231 238
122. Zeng S., Wu J., Liu J., Qi F., Liu B. IL-33 receptor (ST2) signalling is important for regulation of Th2-mediated airway inflammation in a murine model of acute respiratory syncytial virus infection. Scand J Immunol: 2015; 81 6 494 501
123. Miazgowicz M. M., Elliott M. S., Debley J. S., Ziegler S. F. Respiratory syncytial virus induces functional thymic stromal lymphopoietin receptor in airway epithelial cells. J Inflamm Res: 2013; 6 53 61
124. Swedan S., Musiyenko A., Barik S. Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J Virol: 2009; 83 19 9682 9693
125. Lindemans C. A., Coffer P. J., Schellens I. M., de Graaff P. M., Kimpen J. L., Koenderman L. Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-kappaB-dependent mechanism. J Immunol: 2006; 176 9 5529 5537
126. McDermott D. S., Knudson C. J., Varga S. M. Determining the breadth of the respiratory syncytial virus-specific T cell response. J Virol: 2014; 88 6 3135 3143
127. Connors M., Kulkarni A. B., Firestone C. Y., et al. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J Virol: 1992; 66 12 7444 7451
128. Kruijsen D., Schijf M. A., Lukens M. V., et al. Local innate and adaptive immune responses regulate inflammatory cell influx into the lungs after vaccination with formalin inactivated RSV. Vaccine: 2011; 29 15 2730 2741
129. Varga S. M., Wang X., Welsh R. M., Braciale T. J. Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells. Immunity: 2001; 15 4 637 646
130. Stoppelenburg A. J., de Roock S., Hennus M. P., Bont L., Boes M. Elevated Th17 response in infants undergoing respiratory viral infection. Am J Pathol: 2014; 184 5 1274 1279
131. Cautivo K. M., Bueno S. M., Cortes C. M., Wozniak A., Riedel C. A., Kalergis A. M. Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection. J Immunol: 2010; 185 12 7633 7645
132. Brandenburg A. H., de Waal L., Timmerman H. H., Hoogerhout P., de Swart R. L., Osterhaus A. D. HLA class I-restricted cytotoxic T-cell epitopes of the respiratory syncytial virus fusion protein. J Virol: 2000; 74 21 10240 10244
133. Tregoning J. S., Yamaguchi Y., Harker J., Wang B., Openshaw P. J. The role of T cells in the enhancement of respiratory syncytial virus infection severity during adult reinfection of neonatally sensitized mice. J Virol: 2008; 82 8 4115 4124
134. Srikiatkhachorn A., Braciale T. J. Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection. J Exp Med: 1997; 186 3 421 432
135. Chang J., Braciale T. J. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med: 2002; 8 1 54 60
136. DiNapoli J. M., Murphy B. R., Collins P. L., Bukreyev A. Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection. Virol J: 2008; 5 105
137. de Graaff P. M., de Jong E. C., van Capel T. M., et al. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J Immunol: 2005; 175 9 5904 5911
138. Bartz H., Türkel O., Hoffjan S., Rothoeft T., Gonschorek A., Schauer U. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naïve T cells. Immunology: 2003; 109 1 49 57
139. Bromley S. K., Peterson D. A., Gunn M. D., Dustin M. L. Cutting edge: hierarchy of chemokine receptor and TCR signals regulating T cell migration and proliferation. J Immunol: 2000; 165 1 15 19
140. Carreño L. J., Riquelme E. M., González P. A., et al. T-cell antagonism by short half-life pMHC ligands can be mediated by an efficient trapping of T-cell polarization toward the APC. Proc Natl Acad Sci U S A: 2010; 107 1 210 215
141. Lee D. C., Harker J. A., Tregoning J. S., et al. CD25+ natural regulatory T cells are critical in limiting innate and adaptive immunity and resolving disease following respiratory syncytial virus infection. J Virol: 2010; 84 17 8790 8798
142. Durant L. R., Makris S., Voorburg C. M., Loebbermann J., Johansson C., Openshaw P. J. Regulatory T cells prevent Th2 immune responses and pulmonary eosinophilia during respiratory syncytial virus infection in mice. J Virol: 2013; 87 20 10946 10954
143. Reed M., Morris S. H., Jang S., Mukherjee S., Yue Z., Lukacs N. W. Autophagy-inducing protein beclin-1 in dendritic cells regulates CD4 T cell responses and disease severity during respiratory syncytial virus infection. J Immunol: 2013; 191 5 2526 2537
144. Reed M., Morris S. H., Owczarczyk A. B., Lukacs N. W. Deficiency of autophagy protein Map1-LC3b mediates IL-17-dependent lung pathology during respiratory viral infection via ER stress-associated IL-1. Mucosal Immunol: 2015; 8 5 1118 1130
145. Angel Rico M., Trento A., Ramos M., et al. Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes. Immunol Cell Biol: 2009; 87 4 344 350
146. Torres J. P., Gomez A. M., Khokhar S., et al. Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice. Respir Res: 2010; 11 125
147. Rivera-Toledo E., Gómez B. Respiratory syncytial virus persistence in macrophages alters the profile of cellular gene expression. Viruses: 2012; 4 12 3270 3280
148. Li X. Q., Fu Z. F., Alvarez R., Henderson C., Tripp R. A. Respiratory syncytial virus (RSV) infects neuronal cells and processes that innervate the lung by a process involving RSV G protein. J Virol: 2006; 80 1 537 540
149. Tripp R. A., Moore D., Barskey A. IV., et al. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. J Infect Dis: 2002; 185 10 1388 1394
150. O'Donnell D. R., McGarvey M. J., Tully J. M., Balfour-Lynn I. M., Openshaw P. J. Respiratory syncytial virus RNA in cells from the peripheral blood during acute infection. J Pediatr: 1998; 133 2 272 274
151. Thorburn K., Hart C. A. Think outside the box: extrapulmonary manifestations of severe respiratory syncytial virus infection. Crit Care: 2006; 10 4 159
152. Eisenhut M., Sidaras D., Johnson R., Newland P., Thorburn K. Cardiac Troponin T levels and myocardial involvement in children with severe respiratory syncytial virus lung disease. Acta Paediatr: 2004; 93 7 887 890
153. Thorburn K., Eisenhut M., Shauq A., Narayanswamy S., Burgess M. Right ventricular function in children with severe respiratory syncytial virus (RSV) bronchiolitis. Minerva Anestesiol: 2011; 77 1 46 53
154. Checchia P. A., Appel H. J., Kahn S., et al. Myocardial injury in children with respiratory syncytial virus infection. Pediatr Crit Care Med: 2000; 1 2 146 150
155. Giles T. D., Gohd R. S. Respiratory syncytial virus and heart disease. A report of two cases. JAMA: 1976; 236 10 1128 1130
156. Huang M., Bigos D., Levine M. Ventricular arrhythmia associated with respiratory syncytial viral infection. Pediatr Cardiol: 1998; 19 6 498 500
157. Fishaut M., Tubergen D., McIntosh K. Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr: 1980; 96 2 179 186
158. Dabbah H., Glikman D., Zonis Z. Pericardial effusion in an infant with severe respiratory syncytial virus bronchiolitis. Cardiol Young: 2013; 23 2 299 300
159. Eisenhut M., Thorburn K., Ahmed T. Transaminase levels in ventilated children with respiratory syncytial virus bronchiolitis. Intensive Care Med: 2004; 30 5 931 934
160. Nadal D., Wunderli W., Meurmann O., Briner J., Hirsig J. Isolation of respiratory syncytial virus from liver tissue and extrahepatic biliary atresia material. Scand J Infect Dis: 1990; 22 1 91 93
161. Wu J., Wang Z., Wang D. Respiratory virus expression in renal tissues and urine of children with steroid responsive simple nephrotic syndrome. [in Chinese]. Sichuan Da Xue Xue Bao Yi Xue Ban: 2007; 38 969 972
162. Liu X. M., Wang Z., Guo Y. Respiratory syncytial virus nephropathy in rats. Kidney Int: 2007; 71 5 388 396
163. Morichi S., Kawashima H., Ioi H., et al. Classification of acute encephalopathy in respiratory syncytial virus infection. J Infect Chemother: 2011; 17 6 776 781
164. Eisenhut M. Cerebral involvement in respiratory syncytial virus disease. Brain Dev: 2007; 29 7 454
165. Millichap J. J., Wainwright M. S. Neurological complications of respiratory syncytial virus infection: case series and review of literature. J Child Neurol: 2009; 24 12 1499 1503
166. Miyamoto K., Fujisawa M., Hozumi H., et al. Systemic inflammatory response syndrome and prolonged hypoperfusion lesions in an infant with respiratory syncytial virus encephalopathy. J Infect Chemother: 2013; 19 5 978 982
167. Kawashima H., Kashiwagi Y., Ioi H., et al. Production of chemokines in respiratory syncytial virus infection with central nervous system manifestations. J Infect Chemother: 2012; 18 6 827 831
168. Kho N., Kerrigan J. F., Tong T., Browne R., Knilans J. Respiratory syncytial virus infection and neurologic abnormalities: retrospective cohort study. J Child Neurol: 2004; 19 11 859 864
169. Antonucci R., Fanos V. Acute encephalopathy associated with respiratory syncytial virus infections in childhood. A literature review. Minerva Pediatr: 2005; 57 3 137 142
170. Otake Y., Yamagata T., Morimoto Y., et al. Elevated CSF IL-6 in a patient with respiratory syncytial virus encephalopathy. Brain Dev: 2007; 29 2 117 120
171. Rayyan M., Naulaers G., Daniels H., Allegaert K., Debeer A., Devlieger H. Characteristics of respiratory syncytial virus-related apnoea in three infants. Acta Paediatr: 2004; 93 6 847 849
172. Lindgren C., Grögaard J. Reflex apnoea response and inflammatory mediators in infants with respiratory tract infection. Acta Paediatr: 1996; 85 7 798 803
173. Piedimonte G. Pathophysiological mechanisms for the respiratory syncytial virus-reactive airway disease link. Respir Res: 2002; 3 01 S21 S25
174. Espinoza J. A., Bohmwald K., Céspedes P. F., et al. Impaired learning resulting from respiratory syncytial virus infection. Proc Natl Acad Sci U S A: 2013; 110 22 9112 9117
175. Deacon R. M. Digging and marble burying in mice: simple methods for in vivo identification of biological impacts. Nat Protoc: 2006; 1 1 122 124
176. Vorhees C. V., Williams M. T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat Protoc: 2006; 1 2 848 858
177. Donnerstein R. L., Berg R. A., Shehab Z., Ovadia M. Complex atrial tachycardias and respiratory syncytial virus infections in infants. J Pediatr: 1994; 125 1 23 28
178. Menchise A. Myocarditis in the setting of RSV bronchiolitis. Fetal Pediatr Pathol: 2011; 30 1 64 68
179. Puchkov G. F., Min'kovich B. M. Respiratory syncytial infection in a child complicated by interstitial myocarditis with fatal outcome [in Russian]. Arkh Patol: 1972; 34 1 70 73
180. Akins P. T., Belko J., Uyeki T. M., Axelrod Y., Lee K. K., Silverthorn J. H1N1 encephalitis with malignant edema and review of neurologic complications from influenza. Neurocrit Care: 2010; 13 3 396 406
181. Zlateva K. T., Van Ranst M. Detection of subgroup B respiratory syncytial virus in the cerebrospinal fluid of a patient with respiratory syncytial virus pneumonia. Pediatr Infect Dis J: 2004; 23 11 1065 1066